Bluebird suspends studies of sickle cell gene therapy following cancer diagnoses in two more treated patients
Bluebird Bio said Tuesday that it has suspended clinical trials involving its gene therapy for sickle cell disease after receiving reports that two patients treated with the one-time therapy were …
Read More